Xeris Biopharma Holdings, Inc. XERS Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s price / sales?
- Xeris Biopharma Holdings, Inc. (XERS) reported price / sales of 3.2× in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s price / sales changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s price / sales decreased by 16.4% year-over-year, from 3.8× to 3.2×.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s price / sales?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s price / sales has grown at a -11.8% compound annual growth rate (CAGR), from 7.4× to 4.5×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.